CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (6570)
Regenesance is a specialty pharmaceutical company developing drugs to treat acute and chronic nerve disorders.
Company (Alive / Active)
Meibergdreef 45
R-Noord 01-152
1105 BA
Netherlands
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Antibodies that bind human c6 and uses thereof | Jun 16, 2017 | Jun 09, 2020 | Patent |
| Complement antagonists and uses thereof | Mar 12, 2014 | Jul 28, 2015 | Patent |
| Complement antagonists and uses thereof | Jul 10, 2009 | Apr 22, 2014 | Patent |
| Complement inhibition for improved nerve regeneration | Oct 10, 2007 | Apr 22, 2014 | Patent |
| Antibodies that bind human c6 and uses thereof | May 01, 2020 | Application |
